R&D
European launch: Manufacturing as cornerstone for success
In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.
Patients
Why Britain's blood tests are only as reliable as the journe...
What happens in phlebotomy has a huge impact in pathology, and the different funding streams and management means that interests are no longer aligned
Patients
Moving beyond intent: Building more diverse clinical trials
Improving representation is not simply about increasing awareness or setting enrolment targets. It requires identifying and removing the barriers.
Oncology
Sponsored
Establishing ctDNA as a validated primary surrogate endpoint
Circulating tumour DNA (ctDNA) has emerged as a promising primary surrogate endpoint in solid tumour oncology.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
